Malaysian National Cardiovascular Disease Database (NCVD) – Acute Coronary Syndrome (ACS) registry: How are we different?

2011 ◽  
Vol 6 (3) ◽  
pp. 81-89 ◽  
Author(s):  
Wan Azman Wan Ahmad ◽  
Robaayah Zambahari ◽  
Omar Ismail ◽  
Jeyaindran Sinnadurai ◽  
Azhari Rosman ◽  
...  
Author(s):  
Michele Correale ◽  
Francesca Croella ◽  
Alessandra Leopizzi ◽  
Pietro Mazzeo ◽  
Lucia Tricarico ◽  
...  

AbstractCOVID-19 pandemic has negatively impacted the management of patients with acute and chronic cardiovascular disease: acute coronary syndrome patients were often not timely reperfused, heart failure patients not adequately followed up and titrated, atrial arrhythmias not efficaciously treated and became chronic. New phenotypes of cardiovascular patients were more and more frequent during COVID-19 pandemic and are expected to be even more frequent in the next future in the new world shaped by the pandemic. We therefore aimed to briefly summarize the main changes in the phenotype of cardiovascular patients in the COVID-19 era, focusing on new clinical challenges and possible therapeutic options.


2011 ◽  
Vol 10 (6) ◽  
pp. 112-123
Author(s):  
I. S. Yavelov

The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly age, heparin medication change, or abnormal body weight), when the optimal balance between effectiveness and safety requires modifying the standard treatment protocols.


2020 ◽  
Vol 31 (3) ◽  
pp. 300-305
Author(s):  
Robert J. Widmer ◽  
Megha Prasad ◽  
Mohammed Gomaa ◽  
Jaskanwal Deep S. Sara ◽  
Martin K. Reriani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document